Skip to main content
NIH funding notice PAR-23-091

Building in vivo Preclinical Assays of Circuit Engagement for Application in Therapeutic Development (R01 Clinical Trial Not Allowed)

Closed on January 7, 2025.

Posted
January 6, 2023
Close date
January 7, 2025
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,377,384 in first-year total cost, median $688,692.

Most frequent study sections

  1. Pathophysiological Basis of Mental Disorders and Addictions Study Section[PMDA]2

Most frequent institutions

  1. LIEBER INSTITUTE, INC.1
  2. UNIVERSITY OF CALIFORNIA, SAN DIEGO1
Competing awards under PAR-23-091 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2024Validation of electrophysiological biomarkers associated with performance in a preclinical assay of sustained attention1R01MH137057-01CARR, GREGORY VMARTINOWICH, KERILIEBER INSTITUTE, INC., MD$753,016PMDA
2024Neurophysiological biomarkers in preclinical assays of risk propensity1R56MH137332-01DULAWA, STEPHANIE CUNIVERSITY OF CALIFORNIA, SAN DIEGO, CA$624,368PMDA

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.